The Accelerate.EU has been officially launched with the ambitious goal of establishing a resilient and strategic European autonomy in alpha therapies. This collaboration brings together 17 leading European institutions and companies across 9 countries, blending academic expertise with industrial innovation.

The project is coordinated by the Institut Jules Bordet and IBA RadioPharma Solutions
Institut de Cancérologie de l’Ouest (ICO), Erasmus MC, Arronax, Forschungszentrum Jülich, Rigshospitalet, Københavns Universitet – University of Copenhagen, Inserm, SCK CEN, Campus da Universidade de Coimbra na Figueira da Foz, TetraKit Technologies, Oncidium foundation, LabLogic Group, Vicomtech, Université libre de Bruxelles, National Centre for Nuclear Research

Stay Stuned for the evolution of the project!